# South Korea Porcine Vaccines Market

> South Korea Porcine Vaccines Market Research Report By Type (Inactivated vaccines, Live attenuated vaccines, Toxoid vaccines, Recombinant vaccines, Conjugate vaccines, DNA vaccines), By Disease Indication (PED (Porcine Epidemic Diarrhea), PRRS (Porcine Reproductive & Respiratory Syndrome), Swine influenza, Aujeszky's disease (AD), Porcine Circovirus Associated Disease (PCVAD), Others) and By End-user (Veterinary Hospitals, Hog Production Farm) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 6.2%
- **2024:** $ 48 Million
- **2025:** $ 50.98 Million
- **2035:** $ 93 Million
- **Key Players:** Zoetis (US), Merck Animal Health (US), Boehringer Ingelheim (DE), Elanco Animal Health (US), Ceva Santé Animale (FR), Virbac (FR), Heska Corporation (US), Vetoquinol (FR)

**Report ID:** MRFR/Pharma/48722-HCR · **Pages:** 200 · **Author:** Vikita Thakur & Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/south-korea-porcine-vaccines-market-50479

---

## Market Summary

## **South Korea Porcine Vaccines Market Overview**

As per MRFR analysis, the South Korea Porcine Vaccines Market Size was estimated at 44.75 (USD Million) in 2023. The South Korea Porcine Vaccines Market Industry is expected to grow from 48(USD Million) in 2024 to 120 (USD Million) by 2035. The South Korea Porcine Vaccines Market CAGR (growth rate) is expected to be around 8.687% during the forecast period (2025 - 2035)

### **Key South Korea Porcine Vaccines Market Trends Highlighted**

The South Korea porcine vaccine market is growing rapidly due to increased concern over animal health, food safety, and biosecurity on the part of pig farmers. Further exacerbating the problem were escalations in the cases of porcine diseases such as African Swine Fever, which require proper vaccination programs to be implemented. Moreover, the sustained attempts of the South Korean government to promote livestock farming with the aid of R&D resources in veterinary medicine are increasingly shedding light on these areas. There exists a need for comprehensive vaccination programs that can keep pace with new evolving strains of diseases affecting pigs.

There is also scope for the application of biotechnology to enhance vaccine potency.

In the region, there is a growing concern for the welfare of animals, which has a positive impact on the demand for vaccines aimed at making livestock healthier. Moreover, the government policy has been supporting the initiative to modernize farming by expanding the use of health management systems, such as vaccination programs. Investment is being directed into the regional production facilities for the vaccines in the context of productivity-enhancing initiatives that aim at maintaining a balanced farm ecosystem. There is also increasing collaboration between the government and private sectors for the development and improvement of vaccines.

These public policies, combined with the focus on disease prevention and stringent legal frameworks, are anticipated to foster the productive development of the market for porcine vaccines in South Korea. As farmers gradually understand the economic value provided by vaccination programs, this is expected to improve the overall stability and productivity of the pork industry in the region.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **South Korea P****o****rcine Vaccines Market Drivers**

### **Increasing Demand for Animal Protein Consumption**

In South Korea, the rising population and changing dietary preferences have led to an increased demand for animal protein, particularly pork. According to the Ministry of Agriculture, Food and Rural Affairs in South Korea, pork consumption accounts for nearly 60% of total meat consumption in the country. This escalating demand for pork increases the necessity for effective vaccinations in pig farming to ensure livestock health and prevent disease outbreaks, thus driving the South Korea Porcine Vaccines Market Industry.

The rising number of pig farms is also a significant factor, with approximately 6,200 registered pig farms as of the latest government report, further supporting the market growth of porcine vaccines as farmers aim to improve the health and productivity of their herds.

### **Government Initiatives and Support for Livestock Health**

The South Korean government has prioritized livestock health through various initiatives and programs. A recent policy introduced by the Ministry of Agriculture aims to enhance biosecurity measures across pig farms, which includes the establishment of vaccination protocols and funding for research initiatives on vaccine development. Government investment in the Veterinary Sector, which reached over USD 100 million in 2022, underscores commitment to improving livestock management practices, including the adoption of porcine vaccines.

This proactive governmental stance serves to bolster the South Korea Porcine Vaccines Market Industry as farmers are encouraged to adopt vaccination as a key component for disease prevention in swine.

### **Rising Incidence of Porcine Diseases**

The emergence and re-emergence of porcine diseases, such as African Swine Fever (ASF) and Porcine Respiratory Disease Complex (PRDC), have heightened the focus on vaccination among farmers in South Korea. The Animal and Plant Quarantine Agency reported that South Korea experienced outbreaks of ASF in 2019, leading to significant economic implications and loss in the swine population. The urgent need for preventive measures against these diseases has prompted an increased willingness among pig farmers to invest in effective vaccines, thus stimulating growth in the South Korea Porcine Vaccines Market Industry.

The demand for innovative vaccines to counter these prevalent diseases is expected to rise in line with the authorities' implementation of stringent biosecurity measures.

### **Technological Advancements in Vaccine Development**

Technological advancements in vaccine development, such as the emergence of recombinant vaccines and DNA-based vaccines, are contributing to the growth of the South Korea Porcine Vaccines Market Industry. Companies engaged in Research and Development, such as LG Chem and Hanall Biopharma, are actively investing in innovative solutions to enhance vaccine efficacy and safety. The recent approval of a new vaccine formulation that has shown a 30% improvement in efficacy compared to traditional vaccines has been well-received in the market.

Such improvements not only address health concerns but also build trust among farmers, further driving the demand for porcine vaccines in South Korea’s rapidly evolving livestock industry.

## **South Korea Porcine Vaccines Market Segment Insights**

### **Porcine Vaccines Market Type Insights**

The South Korea Porcine Vaccines Market exhibits a diverse and intricate landscape, particularly when examining the Type segment. This market is influenced by multiple factors, including the increasing demand for effective animal health solutions in the livestock sector, driven by the growing concerns over animal diseases and the safety of meat products. 

Inactivated vaccines play a significant role as they provide robust immunity to pigs without causing disease, making them a preferred choice among farmers. Live attenuated vaccines, on the other hand, are valued for their ability to stimulate a strong immune response with fewer doses compared to inactivated forms, thus appealing to producers looking for cost-effective solutions.Toxoid vaccines are particularly important as they target specific toxins produced by pathogens, ensuring that pigs develop immunity against these harmful substances without the risk of disease transmission. 

Recombinant vaccines represent an innovative approach in the South Korea Porcine Vaccines Market; they are designed to produce specific antigens, thereby enhancing both safety and efficacy. Conjugate vaccines are gaining traction as they improve immune responses by linking polysaccharides to proteins, offering a more robust defense mechanism against infections.Lastly, DNA vaccines are emerging as a novel solution, allowing for the rapid development of vaccines that prompt an immune response without using live pathogens, which aligns well with the industry's shift towards safer and more effective animal health management. 

The increasing investment in Research and Development, coupled with supportive government initiatives in South Korea, further stimulates growth in these segments as the industry continuously strives to enhance productivity and mitigate the impact of diseases in the swine population.The overall dynamics of the South Korea Porcine Vaccines Market Type segmentation reflects a focused approach towards improving livestock health, fostering innovation, and responding to the evolving needs of the agricultural sector.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Porcine Vaccines Market Disease Indication Insights**

The South Korea Porcine Vaccines Market, with a significant focus on disease indications, is shaped by various critical factors influencing the health of swine populations. Conditions such as Porcine Epidemic Diarrhea (PED) and Porcine Reproductive and Respiratory Syndrome (PRRS) are notable contributors to increasing vaccine demand, as these diseases can lead to high mortality rates and economic losses for farmers. The prevalence of Swine influenza and Aujeszky's disease also necessitates effective vaccination strategies to mitigate outbreaks.

In addition, the impact of Porcine Circovirus Associated Disease (PCVAD) continues to challenge producers, leading to a push for innovative vaccine solutions amidst rising herd protection needs.

The South Korean market is characterized by a concerted effort to enhance biosecurity measures driven by government policies promoting animal health and welfare. As agricultural practices evolve, the demand for effective vaccination against these diseases remains critical, signifying the importance of research and development efforts focused on vaccine advancements within the market. This landscape highlights a continuous opportunity for growth within the South Korea Porcine Vaccines Market as producers seek to safeguard their livestock against these prevalent diseases.

### **Porcine Vaccines Market End-user Insights**

The South Korea Porcine Vaccines Market has a prominent focus on the End-user segment, with key contributors being Veterinary Hospitals and Hog Production Farms. Veterinary Hospitals play a vital role in administering vaccines and ensuring proper health standards for pigs, thus enhancing livestock health management. The increasing number of veterinary practices within the country supports the growth of porcine vaccines as more facilities adopt advanced healthcare solutions for livestock. Conversely, Hog Production Farms dominate the landscape as they are responsible for the majority of swine production.These farms require an effective vaccination strategy to minimize disease outbreaks and improve overall productivity. 

The growing demand for pork in South Korea, driven by a rising population and changing dietary preferences, places an added emphasis on maintaining herd health and biosecurity measures. The collaboration between veterinary professionals and hog farmers is essential for implementing vaccination programs that can mitigate diseases, ensuring both animal welfare and economic stability within the industry. Overall, the End-user segment demonstrates significant potential within the South Korea Porcine Vaccines Market, driven by the need for robust animal health solutions and increased production efficiency.

### **South Korea Porcine Vaccines Market Key Players and Competitive Insights**

The competitive landscape of the South Korea Porcine Vaccines Market is characterized by a growing need for innovative solutions to combat prevalent diseases affecting swine populations. The market has experienced significant expansion due to increasing pork consumption and heightened awareness among livestock producers regarding the importance of vaccination in maintaining herd health. As the demand for high-quality pork escalates, the importance of reliable vaccine options for swine has come to the forefront. This has encouraged several players to enhance their research and development capabilities while also focusing on the establishment of strategic partnerships to reinforce their market position. 

Given the specific challenges posed by diseases such as Porcine Reproductive and Respiratory Syndrome, the need for effective vaccination strategies is increasingly paramount in the region.Hipra holds a notable position within the South Korea Porcine Vaccines Market, featuring an established portfolio of vaccines specifically designed for swine diseases. The company's strengths lie in its robust research and development framework, enabling the introduction of innovative vaccines that cater to the unique requirements of local livestock producers. Hipra has built solid relationships with local veterinarians and animal health professionals, enhancing its market presence through effective collaboration. 

Additionally, the company's commitment to quality assurance and regulatory compliance has reinforced the trust of local stakeholders, ensuring a competitive edge in terms of product reliability and effectiveness. Hipra's investment in local production facilities further signifies its dedication to addressing the demands of the South Korean market while fostering sustainable practices within the industry.Phibro Animal Health has also made significant inroads into the South Korea Porcine Vaccines Market, focusing on delivering a comprehensive range of products aimed at enhancing swine health. 

The company is recognized for its vaccine offerings that target systemic and respiratory diseases, which remain critical concerns for Korean pig farmers. Phibro's strengths stem from its innovative approach to vaccine development, backed by substantial resources dedicated to research and clinical studies. Additionally, the company actively seeks opportunities for growth through strategic mergers and acquisitions, integrating advanced technologies, and expanding its product lines in alignment with market needs. Phibro’s established distribution network in South Korea enables it to respond quickly to market demands, enhancing its service delivery and customer engagement.

### **Key Companies in the South Korea Porcine Vaccines Market Include**

## **South Korea Porcine Vaccines Market Industry Developments**

The South Korea Porcine Vaccines Market has witnessed notable developments, particularly with advances in vaccine technology aimed at enhancing swine health and productivity. Recent initiatives from companies like Zoetis, Merck Animal Health, and Boehringer Ingelheim have focused on innovative vaccine formulations to control prevalent swine diseases such as Porcine Reproductive and Respiratory Syndrome (PRRS). In terms of market dynamics, a significant partnership was formed in August 2023 between Virbac and a leading South Korean research institution to bolster R&D in advanced vaccine strategies.

Additionally, Hipra has expanded its production capacity in South Korea to meet rising domestic and export demands, reflecting the increasing awareness of biosecurity among swine farmers. The market has been positively influenced by a 15% annual growth rate in the adoption of vaccination programs in swine, as reported by the Ministry of Agriculture, Food and Rural Affairs. In July 2023, Phibro Animal Health announced an acquisition of a local biotech firm, enhancing its product portfolio in the region. These trends underscore South Korea's commitment to strengthening its animal health landscape, driven by innovation and collaboration among leading companies.

## **South Korea Porcine Vaccines Market Segmentation Insights**

## Market Drivers

### Rising Pork Consumption

The increasing consumption of pork in South Korea is significantly impacting the porcine vaccines market. As pork remains a staple protein source for many South Koreans, the demand for healthy and disease-free pigs is paramount. This trend is expected to drive farmers to invest more in vaccination programs to ensure the health of their livestock. Recent statistics indicate that pork consumption in South Korea has risen by approximately 3% annually, leading to a corresponding increase in the need for effective vaccines. Consequently, the porcine vaccines market is likely to expand as producers seek to enhance the health and productivity of their herds to meet consumer demand.

### Advancements in Vaccine Technology

Technological advancements in vaccine development are playing a crucial role in shaping the porcine vaccines market. Innovations such as recombinant vaccines and adjuvant technologies are enhancing the efficacy and safety of vaccines available for swine. These advancements not only improve the immune response in pigs but also reduce the incidence of adverse effects, making vaccination more appealing to farmers. The introduction of new vaccine formulations is expected to increase market penetration, as producers are more likely to adopt products that demonstrate superior performance. As a result, the porcine vaccines market is anticipated to witness substantial growth driven by these technological improvements.

### Increasing Awareness of Animal Health

The growing awareness regarding [animal health](https://www.marketresearchfuture.com/reports/animal-health-market-7163) and welfare in South Korea is driving the porcine vaccines market. Farmers and producers are increasingly recognizing the importance of vaccination in preventing diseases that can affect swine populations. This heightened awareness is likely to lead to a rise in vaccination rates, thereby boosting demand for porcine vaccines. According to recent data, the swine population in South Korea is approximately 10 million, and with the increasing focus on biosecurity measures, the market for vaccines is projected to grow at a CAGR of around 5% over the next few years. This trend indicates a shift towards more proactive health management practices in the livestock sector. Such practices are essential for maintaining productivity and profitability in the porcine industry.

### Economic Incentives for Disease Prevention

Economic factors are significantly influencing the porcine vaccines market in South Korea. The rising costs associated with disease outbreaks in swine herds are prompting farmers to invest in preventive measures, including vaccination. By vaccinating their livestock, producers can mitigate the financial risks associated with disease management and loss of productivity. Recent analyses suggest that the economic impact of swine diseases can lead to losses exceeding $100 million annually in South Korea. Consequently, the porcine vaccines market is likely to benefit from this economic rationale, as farmers seek to protect their investments and ensure the sustainability of their operations.

### Regulatory Support for Vaccination Programs

Regulatory frameworks in South Korea are increasingly supportive of vaccination programs, which is beneficial for the porcine vaccines market. The government has implemented policies that encourage the use of vaccines to control and prevent swine diseases. This regulatory support is likely to enhance the adoption of vaccination practices among farmers, thereby increasing the overall market size. Furthermore, initiatives aimed at educating farmers about the benefits of vaccination are expected to foster a more robust market environment. As a result, the porcine vaccines market is projected to grow as compliance with vaccination regulations becomes more prevalent among livestock producers.

## Future Outlook

The [Porcine Vaccines Market](https://www.marketresearchfuture.com/reports/porcine-vaccines-market-7438) in South Korea is projected to grow at a 6.2% CAGR from 2025 to 2035, driven by increasing disease outbreaks and advancements in vaccine technology.

**New opportunities:**

- Development of customized vaccine formulations for specific regional diseases. Expansion of e-commerce platforms for vaccine distribution. Investment in R&D for next-generation vaccine delivery systems.

By 2035, the porcine vaccines market is expected to achieve substantial growth and innovation.

## Segment Insights

### By Type: Inactivated vaccines (Largest) vs. Live attenuated vaccines (Fastest-Growing)

In the South Korea porcine vaccines market, the distribution of market share among different vaccine types reveals inactivated vaccines as the dominant segment, capturing a significant portion of the market. Following closely are live attenuated vaccines, which have started to gain traction due to their effective immunization capacity and lower production costs. The other types, including toxoid, recombinant, conjugate, and DNA vaccines, hold smaller market shares but contribute significantly to the overall diversity of vaccine options available. Growth trends indicate a strong future for live attenuated vaccines, driven by increasing awareness of porcine health and the need for effective disease management. Additionally, advancements in vaccine technology and increased R&D investments are propelling these vaccines to the forefront. The inactivated vaccines remain critical, but their growth is steady rather than rapid, as new innovations emerge within the sector, targeting enhanced immune responses and production efficiencies.

Inactivated vaccines (Dominant) vs. Recombinant vaccines (Emerging)

Inactivated vaccines hold a dominant position in the South Korea porcine vaccines market, characterized by their ability to evoke strong immune responses without the risk of causing disease in the vaccinated population. Their widespread usage is attributed to the reliability and safety they offer, making them a preferred choice among livestock producers. On the other hand, recombinant vaccines represent an emerging segment, showing promise in terms of specificity and efficiency. They utilize cutting-edge biotechnology to create targeted immune responses, appealing to modern practices in veterinary medicine. As these technologies advance, recombinant vaccines are expected to carve out a larger share of the market, particularly among producers seeking innovative solutions to enhance herd health.

### By Disease Indication: PED (Largest) vs. PRRS (Fastest-Growing)

In the South Korea porcine vaccines market, the distribution of market share among disease indications reveals that Porcine Epidemic Diarrhea (PED) is the largest segment, holding a significant portion of the market. Other critical contributors include PRRS, Swine Influenza, Aujeszky's Disease, and Porcine Circovirus Associated Disease (PCVAD), each playing a substantial role in shaping the landscape of porcine vaccines as they target specific health challenges within swine populations. Looking towards growth trends, PRRS has gained traction as the fastest-growing segment due to increasing awareness of its impact on the swine industry. The rising prevalence of these diseases alongside advancements in vaccination technology provides a robust backdrop for market expansion, as stakeholders seek to enhance disease management and improve herd health profitability.

PED (Dominant) vs. PCVAD (Emerging)

Porcine Epidemic Diarrhea (PED) stands out as the dominant disease indication, significantly impacting pig health and productivity. The extensive adoption of PED vaccines highlights their critical role in minimizing outbreaks and ensuring swine welfare. In contrast, Porcine Circovirus Associated Disease (PCVAD) is emerging, driven by evolving understanding and recognition of its effects on livestock. With advancements in vaccine formulations and delivery systems, the PCVAD sector exhibits potential for substantial growth. Together, these segments illustrate the dynamic nature of the South Korea porcine vaccines market, catering to specific health threats that demand focused and innovative solutions.

### By End-user: Veterinary Hospitals (Largest) vs. Hog Production Farm (Fastest-Growing)

In the South Korea porcine vaccines market, Veterinary Hospitals hold the largest share, reflecting their critical role in managing the health and well-being of pigs. They serve as primary points for vaccine administration, diagnostics, and treatment, thus significantly influencing the market dynamics. Conversely, Hog Production Farms are emerging as the fastest-growing segment due to their increasing demand for efficient herd management practices and a surge in large-scale operations seeking to enhance productivity. Current growth trends in this segment are driven by heightened awareness of swine diseases and the necessity for effective vaccination regimes. Moreover, advancements in vaccine technology and a focus on biosecurity measures are encouraging more farms to adopt comprehensive vaccination strategies. As livestock operators strive for increased production efficiency, the reliance on both Veterinary Hospitals and Hog Production Farms is set to intensify, reflecting an evolving market landscape.

Veterinary Hospitals (Dominant) vs. Hog Production Farm (Emerging)

Veterinary Hospitals play a dominant role in the South Korea porcine vaccines market, acting as essential hubs for animal healthcare. They are equipped with skilled professionals and advanced diagnostics tools, ensuring that pigs receive timely vaccinations and treatments. Their established trust with livestock owners contributes to their sustained market share, making them vital in controlling disease outbreaks. On the other hand, Hog Production Farms are recognized as an emerging segment, increasingly incorporating vaccination programs into their operational protocols. These farms prioritize biosecurity and health management, promoting the use of vaccines as a fundamental part of their production practices. As the demand for high-quality pork rises, the focus on vaccination within these farms is likely to grow, enhancing their importance in the market.

## Competitive Benchmarking

The porcine vaccines market in South Korea is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and regional expansion. Key players such as Zoetis (US), Merck Animal Health (US), and Boehringer Ingelheim (DE) are at the forefront, leveraging their extensive research capabilities and established market presence to drive growth. These companies appear to focus on developing advanced vaccine formulations and enhancing their distribution networks, which collectively fosters a dynamic competitive environment. The emphasis on innovation and strategic collaborations among these firms suggests a trend towards more sophisticated vaccine solutions tailored to local needs.In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance efficiency and responsiveness to market demands. The competitive structure of the market seems moderately fragmented, with several players vying for market share while also collaborating on research initiatives. This fragmentation allows for a diverse range of products and services, catering to the specific needs of the South Korean market, while the influence of major players remains substantial.
In October Zoetis (US) announced the launch of a new vaccine specifically targeting Porcine Reproductive and Respiratory Syndrome (PRRS), a significant advancement in the fight against this prevalent disease. This strategic move not only reinforces Zoetis's commitment to innovation but also positions the company to capture a larger share of the market by addressing a critical health issue affecting swine production. The introduction of this vaccine is likely to enhance the overall health of pig populations, thereby improving productivity for farmers.
In September Merck Animal Health (US) expanded its partnership with local veterinary institutions to enhance research on vaccine efficacy and safety. This collaboration appears to be a strategic effort to leverage local expertise and ensure that their products meet the specific health challenges faced by the South Korean swine industry. By investing in local research, Merck is likely to strengthen its market position and foster trust among local producers, which could lead to increased adoption of its vaccines.
In August Boehringer Ingelheim (DE) launched a digital platform aimed at providing farmers with real-time data on vaccine performance and animal health. This initiative seems to reflect a broader trend towards digitalization in the agricultural sector, where data-driven insights can significantly enhance decision-making processes. By integrating technology into their offerings, Boehringer Ingelheim is likely to differentiate itself from competitors and provide added value to its customers.
As of November the competitive trends in the porcine vaccines market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances among key players are shaping the landscape, fostering innovation and enhancing product offerings. The shift from price-based competition to a focus on technological advancements and supply chain reliability is evident. Moving forward, companies that prioritize innovation and adaptability in their strategies are likely to emerge as leaders in this evolving market.

## Recent News & Developments

The South Korea Porcine Vaccines Market has witnessed notable developments, particularly with advances in vaccine technology aimed at enhancing swine health and productivity. Recent initiatives from companies like Zoetis, Merck Animal Health, and Boehringer Ingelheim have focused on innovative vaccine formulations to control prevalent swine diseases such as Porcine Reproductive and Respiratory Syndrome (PRRS). In terms of market dynamics, a significant partnership was formed in August 2023 between Virbac and a leading South Korean research institution to bolster R&D in advanced vaccine strategies.

Additionally, Hipra has expanded its production capacity in South Korea to meet rising domestic and export demands, reflecting the increasing awareness of biosecurity among swine farmers. The market has been positively influenced by a 15% annual growth rate in the adoption of vaccination programs in swine, as reported by the Ministry of Agriculture, Food and Rural Affairs. In July 2023, Phibro Animal Health announced an acquisition of a local biotech firm, enhancing its product portfolio in the region. These trends underscore South Korea's commitment to strengthening its animal health landscape, driven by innovation and collaboration among leading companies.

## Report Scope

| MARKET SIZE 2024 | 48.0(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 50.98(USD Million) |
| MARKET SIZE 2035 | 93.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.2% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Zoetis (US), Merck Animal Health (US), Boehringer Ingelheim (DE), Elanco Animal Health (US), Ceva Santé Animale (FR), Virbac (FR), Heska Corporation (US), Vetoquinol (FR) |
| Segments Covered | Type, Disease Indication, End-user |
| Key Market Opportunities | Advancements in vaccine technology enhance disease prevention in the porcine vaccines market. |
| Key Market Dynamics | Rising demand for innovative porcine vaccines driven by regulatory changes and technological advancements in South Korea. |
| Countries Covered | South Korea |

## Frequently Asked Questions

**Q: What was the market valuation of the porcine vaccines market in 2024?**
A: The market valuation of the porcine vaccines market was $48.0 Million in 2024.

**Q: What is the projected market valuation for 2035?**
A: The projected market valuation for 2035 is $93.0 Million.

**Q: What is the expected CAGR for the porcine vaccines market during the forecast period 2025 - 2035?**
A: The expected CAGR for the porcine vaccines market during the forecast period 2025 - 2035 is 6.2%.

**Q: Which companies are the key players in the porcine vaccines market?**
A: Key players in the porcine vaccines market include Zoetis, Merck Animal Health, Boehringer Ingelheim, Elanco Animal Health, Ceva Santé Animale, Virbac, Heska Corporation, and Vetoquinol.

**Q: What are the main types of vaccines in the porcine vaccines market?**
A: The main types of vaccines in the porcine vaccines market include inactivated vaccines, live attenuated vaccines, toxoid vaccines, recombinant vaccines, conjugate vaccines, and DNA vaccines.

**Q: What was the market size for live attenuated vaccines in 2024?**
A: The market size for live attenuated vaccines was $15.0 Million in 2024, with a projected increase to $30.0 Million.

**Q: How much is the market for Porcine Reproductive & Respiratory Syndrome (PRRS) vaccines expected to grow?**
A: The market for PRRS vaccines was $15.0 Million in 2024 and is expected to reach $30.0 Million by 2035.

**Q: What is the market size for veterinary hospitals as an end-user segment?**
A: The market size for veterinary hospitals as an end-user segment was $20.0 Million in 2024, with projections up to $38.0 Million.

**Q: What is the projected market size for hog production farms by 2035?**
A: The projected market size for hog production farms is expected to reach $55.0 Million by 2035.

**Q: What are the expected growth trends for the porcine vaccines market in South Korea?**
A: The porcine vaccines market in South Korea appears to be on a growth trajectory, with a projected valuation increase from $48.0 Million in 2024 to $93.0 Million by 2035.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-korea-porcine-vaccines-market-50479*